Pipeline Watch: Top-Line Phase III Results For Esketamine, ALKS-5461 And Quizartinib
Executive Summary
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.